ANI Pharmaceuticals
ANIP
ANIP
190 hedge funds and large institutions have $543M invested in ANI Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 54 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 170 → 190 (+20)
5.25% more ownership
Funds ownership: 59.76% → 65% (+5.2%)
6% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 54
Holders
190
Holding in Top 10
2
Calls
$6.86M
Puts
$3.26M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$8.72M | |
| 3 | +$7.52M | |
| 4 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
+$6.81M |
| 5 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$4.91M |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$2.65M | |
| 3 | -$2.1M | |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$1.99M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.52M |